COLAPIETRO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 722
EU - Europa 497
AS - Asia 162
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.385
Nazione #
US - Stati Uniti d'America 721
IE - Irlanda 192
CN - Cina 100
DE - Germania 99
IT - Italia 59
SE - Svezia 46
TR - Turchia 37
UA - Ucraina 35
GB - Regno Unito 20
CZ - Repubblica Ceca 17
SG - Singapore 10
VN - Vietnam 10
FR - Francia 9
BE - Belgio 8
FI - Finlandia 5
IN - India 3
EU - Europa 2
RU - Federazione Russa 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
CR - Costa Rica 1
HK - Hong Kong 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 1.385
Città #
Chandler 194
Dublin 188
Jacksonville 133
New York 41
Ann Arbor 32
Ashburn 32
Izmir 27
Nanjing 26
Grafing 24
Bremen 23
Lawrence 23
Princeton 23
L'aquila 20
Beijing 19
Wilmington 18
Brno 16
Munich 15
Boardman 13
Dong Ket 10
Brussels 8
Nanchang 8
Woodbridge 8
Berlin 7
Falls Church 7
San Mateo 7
Singapore 7
Tianjin 7
Dearborn 6
L’Aquila 6
Washington 5
Zhengzhou 5
Changsha 4
Des Moines 4
Jinan 4
Kunming 4
Los Angeles 4
Norwalk 4
Rome 4
Seattle 4
Hebei 3
Milan 3
Shanghai 3
Tappahannock 3
Cedar Knolls 2
Frankfurt am Main 2
Fremont 2
Garland 2
Guangzhou 2
Hanover 2
Jiaxing 2
Menlo Park 2
Piombino Dese 2
Pune 2
Shenyang 2
Termoli 2
Verona 2
Amsterdam 1
Carlentini 1
Casoria 1
Edinburgh 1
Fairfield 1
Hangzhou 1
Houston 1
Irkutsk 1
Mountain View 1
Napoli 1
Ningbo 1
Orange 1
Oslo 1
Pavia 1
Perth 1
San Diego 1
San Francisco 1
San José 1
Shreveport 1
Taizhou 1
Tirana 1
Tokyo 1
Vienna 1
Warsaw 1
Totale 1.052
Nome #
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 108
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 102
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 94
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 93
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 78
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 76
Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse 72
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 66
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 64
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 59
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 58
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 57
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 56
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 55
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 53
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? 52
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 49
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 47
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 44
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 40
The importance of tumor stem cells in glioblastoma resistance to therapy 39
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 36
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 34
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 15
Totale 1.447
Categoria #
all - tutte 5.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020172 25 4 17 5 3 20 32 6 22 17 0 21
2020/2021176 7 19 2 22 18 6 24 0 27 8 27 16
2021/2022176 8 0 21 8 5 31 5 5 14 32 10 37
2022/2023555 29 42 10 76 35 58 0 44 234 2 14 11
2023/2024169 19 5 8 2 19 61 1 8 0 4 9 33
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 1.447